On the one hand, many molecular pathways and cell functions are involved in regulating tumor immunity, and GBM cells produce effective immune inhibitory molecules, including transforming growth factor-beta (TGF-β), interleukin-10 (IL-10), and indoleamine 2,3-dioxygenase (IDO). This evidence concerns the gene IL10 and glioblastoma.